This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robida, J. M.
Right arrow Articles by Tang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robida, J. M.
Right arrow Articles by Tang, H.

 Previous Article  |  Next Article 

Journal of Virology, June 2007, p. 5829-5840, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02524-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro{triangledown}

John M. Robida,{dagger} Heather B. Nelson,{dagger} Zhe Liu, and Hengli Tang*

Department of Biological Science, Florida State University, Tallahassee, Florida 32306-4370

Received 15 November 2006/ Accepted 11 March 2007

Treatment of hepatitis C virus (HCV) infection has been met with less than satisfactory results due primarily to its resistance to and significant side effects from alpha interferon (IFN-{alpha}). New classes of safe and broadly acting treatments are urgently needed. Cyclosporine (CsA), an immunosuppressive and anti-inflammatory drug for organ transplant patients, has recently been shown to be highly effective in suppressing HCV replication through a mechanism that is distinct from the IFN pathway. Here we report the selection and characterization of HCV replicon cells that are resistant to CsA treatment in vitro, taking advantage of our ability to sort live cells that are actively replicating HCV RNA in the presence of drug treatments. This resistance is specific to CsA as the replicon cells most resistant to CsA were still sensitive to IFN-{alpha} and a polymerase inhibitor. We demonstrate that the resistant phenotype is not a result of general enhanced replication and, furthermore, that mutations in the coding region of HCV NS5B contribute to the resistance. Interestingly, a point mutation (I432V) isolated from the most resistant replicon was able to rescue a lethal mutation (P540A) in NS5B that disrupts its interaction with its cofactor, cyclophilin B (CypB), even though the I432V mutation is located outside of the reported CypB binding site (amino acids 520 to 591). Our results demonstrate that CsA exerts selective pressure on the HCV genome, leading to the emergence of resistance-conferring mutations in the viral genome despite acting upon a cellular protein.

* Corresponding author. Mailing address: Bio Unit I, Chieftan Way, Department of Biological Science, Florida State University, Tallahassee, FL 32306-4370. Phone: (850) 645-2402. Fax: (850) 644-0481. E-mail: tang{at}bio.fsu.edu

{triangledown} Published ahead of print on 21 March 2007.

{dagger} These authors contributed equally to this work.

Journal of Virology, June 2007, p. 5829-5840, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02524-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pawlotsky, J.-M. (2009). Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs. Therapeutic Advances in Gastroenterology 2: 205-219 [Abstract]  
  • Liu, Z., Yang, F., Robotham, J. M., Tang, H. (2009). Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex. J. Virol. 83: 6554-6565 [Abstract] [Full Text]  
  • Chatterji, U., Bobardt, M., Selvarajah, S., Yang, F., Tang, H., Sakamoto, N., Vuagniaux, G., Parkinson, T., Gallay, P. (2009). The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication. J. Biol. Chem. 284: 16998-17005 [Abstract] [Full Text]  
  • Hanoulle, X., Badillo, A., Wieruszeski, J.-M., Verdegem, D., Landrieu, I., Bartenschlager, R., Penin, F., Lippens, G. (2009). Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B. J. Biol. Chem. 284: 13589-13601 [Abstract] [Full Text]  
  • Fang, F., Flegler, A. J., Du, P., Lin, S., Clevenger, C. V. (2009). Expression of Cyclophilin B is Associated with Malignant Progression and Regulation of Genes Implicated in the Pathogenesis of Breast Cancer. Am. J. Pathol. 174: 297-308 [Abstract] [Full Text]  
  • Mathy, J. E., Ma, S., Compton, T., Lin, K. (2008). Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance. Antimicrob. Agents Chemother. 52: 3267-3275 [Abstract] [Full Text]  
  • Chinnaswamy, S., Yarbrough, I., Palaninathan, S., Kumar, C. T. R., Vijayaraghavan, V., Demeler, B., Lemon, S. M., Sacchettini, J. C., Kao, C. C. (2008). A Locking Mechanism Regulates RNA Synthesis and Host Protein Interaction by the Hepatitis C Virus Polymerase. J. Biol. Chem. 283: 20535-20546 [Abstract] [Full Text]  
  • Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., Tang, H. (2008). Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro. J. Virol. 82: 5269-5278 [Abstract] [Full Text]  
  • Okamoto, T., Omori, H., Kaname, Y., Abe, T., Nishimura, Y., Suzuki, T., Miyamura, T., Yoshimori, T., Moriishi, K., Matsuura, Y. (2008). A Single-Amino-Acid Mutation in Hepatitis C Virus NS5A Disrupting FKBP8 Interaction Impairs Viral Replication. J. Virol. 82: 3480-3489 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»